Celebrex

$89 Million Proposed Class Action Settlement Provides Consumers and Insurers With Money Back for Celebrex and Bextra Purchases and Reimbursements

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- A federal court in San Francisco has granted preliminary approval to a proposed settlement with Pfizer Inc. ("Pfizer") about the marketing of the prescription drugs Bextra and Celebrex. The settlement in the case called In re Bextra and Celebrex Mar...

Pfizer Commences Its Advertising for Celebrex with All the Warnings

Pfizer manufactures Celebrex and in 2004 the sales of Celebrex was $3.3 billion worldwide. But after widespread concerns about the drug causing heart attacks the company stopped advertising//. But 16 months later the has returned to the consumer ad market in hopes of reviving sales of the drug, whi...

Potential lung disease biomarkers yield clues to COX-2 inhibitor side effects

...e risk of heart attack, stroke and death in users. celebrex (celecoxib) is the only COX-2 inhibitor still avai...kers and 28 current smokers took 200 milligrams of celebrex twice a day for about a week. At the beginning of ...her levels of COX-2 activity. Twice-daily doses of celebrex resulted in reduced PGE-M levels in all three grou...

Licorice compound offers new cancer prevention strategy

...aglandins. Inhibiting this enzyme with non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or with selective COX-2 inhibitors like Vioxx or celebrex reduces the number and size of colon polyps in mice and in patients with an inherited predisposition to colon cancer. However, both types of drugs ca...

Vioxx's Heart Risk Lingered Long After Use Ended

...ot all NSAIDs. There is a dose-dependent risk with celebrex as well, whose magnitude was not that much differe... cox-2 inhibitors. Whether or not other drugs like celebrex shared that isn't known. That has not been demonst...to be suspicious, particularly since high doses of celebrex have heart attack and stroke risk. But there's nev...

NSAIDs Might Lower Breast Cancer Risk

... included the group of NSAIDs known as cox-2 inhibitors, only one of which, celebrex (celecoxib), is still on the market. NSAID use across all participants i...ore information." A randomized trial looking at the protective effect of celebrex on breast cancer is due to be completed in 2009, Etminan said. More inf...

Horizon Therapeutics Names Timothy P. Walbert as President and CEO

...so served as director, Celebrex(R) North America and arthritis team leader, Asia Pacific, Latin America and Canada at Searle/Pharmacia. He coordinated celebrex activities in Canada, Australia, and Latin America where aggregate sales grew to nearly $400 million in 2000, making it one of the most successful pha...

Anemia Drugs May Speed Tumor Growth in Some Cancer Patients

...lar, patients taking drugs that interfered with protein binding such as Norvasc for high blood pressure, Prilosec for heartburn, and the pain reliever celebrex were more likely to experience hematologic side effects such as low white blood cell counts. Patients taking drugs that act on a group of enzymes k...

Celebrex May Reduce Levels of Lung Cancer Biomarker

...to prevent lung cancer. Researchers report that celebrex (celecoxib), the last remaining cox-2 inhibitor on...e should start taking the drug for this reason, as celebrex has noted cardiovascular side effects, albeit effe.... The researchers were primarily interested in how celebrex might affect Ki-67, a protein that may be related ...

Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial

... The study is the first large randomized trial of celebrex in lung cancer prevention; the findings will be pr...re performed. They then were randomized to receive celebrex at either 200 milligrams (low dose) or 400 milligr...smokers, we were able to see that a higher dose of celebrex could decrease the proliferation marker KI-67 in t...

Celebrex in Biological News

KINAXOs Cellular Target Profiling reveals mTOR as a new target of Celebrex

Martinsried, Germany, April 29, 2009 / b3c newswire / - Kinaxo Biotechnologies GmbH has successfully applied its Cellular Target Profiling® technology to identify the protein kinase mTOR as a new cellular target of celecoxib (Celebrex®, Pfizer). Celecoxib is a non-steroidal, anti-infla...

FDA causes unnecessary scare about common painkillers

...ease. With the non-selective NSAIDs, Europe has given a "clean bill of health" to the agents and the FDA has judged them to have similar risks to celebrex and is adding "black box" warnings. "Decisions by regulatory agencies are expected to follow explicit regulations and should be evidence-based,"...

Combination therapy shows promising results in patients with advanced lung cancer

...ed therapy Tarceva with the anti-inflammatory drug celebrex increased response rates in lung cancer patients b...espond to all conventional therapies, took several celebrex pills and one Tarceva pill each day. After eight w...to determine the safest and most effective dose of celebrex to use in lung cancer. Previously, doses were base...

Pest control research leads to pain control discovery

...ents and found them to be as potent at a low-dose as Vioxx and Celebrex, but without the changes in blood chemistry linked to heart attacks. Vioxx and celebrex belong to a class of drugs known as Cox-2 inhibitors. The enzyme targeted by the newly discovered inhibitors is also found in humans. (Enzymes are pro...

Inflammation and drugs to control this activity studied in a variety of tumors sites

...ic Health at The Ohio State University Medical Center in Columbus and his co-workers looked at the use of selective COX-2 inhibitors such as Vioxx and celebrex between 1999 and 2004 and the incidence of breast cancer. They compared 323 breast cancer cases to 649 healthy controls and found a risk reduction of ...

Therapeutic prospects beyond Vioxx

...e have clarified the mechanism by which drugs like celebrex and Vioxx cause heart problems, in multiple animal... selective inhibitors of COX-2 ?Vioxx, Bextra, and celebrex ?with an increased incidence of heart attack and s... Almost 10 years ago, FitzGerald noticed that both celebrex and Vioxx depressed in healthy individuals a prote...

FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

...is unfavorable. FDA has also asked Pfizer to include a boxed warning in the celebrex (celecoxib) label. Pfizer has agreed to suspend sales and marketing of Bext... gastrointestinal (GI) bleeding associated with their use. Manufacturers of celebrex and all other prescription NSAIDs will be asked to revise their labeling to...

Celebrex in Biological Technology

Describe your invention, or your biotech patent may be worthless

... issued, the University of Rochester filed suit against G.D. Searle & Co., Monsanto Co., Pharmacia Corp, and Pfizer, alleging that the sale of Phizers celebrex and Bextra, both COX-2 inhibitors, infringed upon Rochesters patent. The patent was found to be invalid based upon a failure to meet the written descr...

The greatest life-science developments of 2004

...ular side effects and the resultant scrutiny on the FDA for not being on top of a companys drug reporting. By the way, the recent Pfizer debacle with celebrex in the last two days has confirmed that this cardiovascular side effect may well be a drug class effect. Two long-term issues arise out of this sit...

Why are new drugs failing?

...7 billion, this is still a big decline to the tune of more than $80 billion (or more than the total value of Abbott Labs!). Though major Cox-2 product celebrex is still on the market, this usage will be significantly curtailed due to its potential cardio toxicity and new label warnings. What about poor Mer...